Itai Levi
Impact in
-
- Lymphoma Diagnosis and Treatment
- Hematology top 2%
- Iron Metabolism and Disorders
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
Papers in
-
- Lymphoma Diagnosis and Treatment 24
- Hematology 21
- Acute Myeloid Leukemia Research 10
- Platelet Disorders and Treatments 3
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Ofer Shpilberg (10 shared papers)Isaac Ben‐Bassat (7 shared papers)Ronit Yerushalmi (3 shared papers)Hanna Shalev (4 shared papers)Hannah Tamary (4 shared papers)Galit Perez‐Avraham (5 shared papers)Daniel Benharroch (8 shared papers)Arnon Nagler (7 shared papers)
- Journals
- Blood (10 papers)Hematological Oncology (4 papers)European Journal Of Haematology (4 papers)Annals of Hematology (3 papers)The Lancet (2 papers)
- Partner nations
- IsraelUnited StatesSwitzerland
In The Last Decade
Itai Levi
68 papers receiving 1.6k citations
Itai Levi's Hit Papers
Peers
Comparison fields: 5 of 70
- Pathology and Forensic Medicine 613
- Hematology 408
- Genetics 94
- Family Practice 17
- Oncology 122
Countries citing papers authored by Itai Levi
This map shows the geographic impact of Itai Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itai Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itai Levi more than expected).
Fields of papers citing papers by Itai Levi
This network shows the impact of papers produced by Itai Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itai Levi. The network helps show where Itai Levi may publish in the future.
Co-authors
The 25 scholars most cited alongside Itai Levi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial Hit paper breakdown → | 2018 | 561 |
| 2 | 2008 | 117 | |
| 3 | 2006 | 107 | |
| 4 | 2012 | 87 | |
| 5 | 2011 | 61 | |
| 6 | 2001 | 53 | |
| 7 | 2020 | 50 | |
| 8 | 2004 | 44 | |
| 9 | 2012 | 35 | |
| 10 | 2007 | 34 | |
| 11 | 2022 | 32 | |
| 12 | 2000 | 30 | |
| 13 | 2021 | 28 | |
| 14 | 2020 | 26 | |
| 15 | 2004 | 25 | |
| 16 | 2012 | 21 | |
| 17 | 2011 | 20 | |
| 18 | 2011 | 19 | |
| 19 | 1999 | 17 | |
| 20 | 2005 | 17 |
About Itai Levi
Itai Levi is a scholar working on Pathology and Forensic Medicine, Hematology, Genetics, Toxicology and Family Practice, having authored 70 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (24 papers), Acute Myeloid Leukemia Research (10 papers), Chronic Lymphocytic Leukemia Research (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Platelet Disorders and Treatments (3 papers), Hemoglobinopathies and Related Disorders (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Medication Adherence and Compliance (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (613 citations), Hematology (408 citations), Genetics (94 citations), Family Practice (17 citations) and Oncology (122 citations). Itai Levi has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Ofer Shpilberg, Isaac Ben‐Bassat, Ronit Yerushalmi, Hanna Shalev, Hannah Tamary, Galit Perez‐Avraham, Daniel Benharroch, Arnon Nagler, Dorine W. Swinkels and Abraham Avigdor. Their work appears in journals such as Blood, Hematological Oncology, European Journal Of Haematology, Annals of Hematology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.